Table 5 Injection site pain (safety population).

From: Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

  

Risperidone ISM

Risperidone ISM

Time point

Placebo

75 mg

100 mg

Statistic

N = 147

N = 144

N = 146

VAS pain score

 Mean (SD)

2.4 (2.56)

2.3 (2.31)

2.5 (2.38)

 95% CI

1.9 to 2.8

1.9 to 2.7

2.1 to 2.9

 Median

2.0

2.0

2.0

 IQR

0.0 to 4.0

0.0 to 3.0

0.0 to 4.0

 Min

0

0

0

 Max

10

9

10

  1. CI confidence interval, IQR interquartile range, SD standard deviation, VAS visual analog scale. The overall summary presents incidence for each reaction category and maximum VAS score.
Back to article page